Advances in Urology

Research Article

Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities

Table 2

Characteristics at enrollment.


	Mean ± SD, median, Min-Max, n

Demographics
Age (years)	77.1 ± 10.6, 78, 50–97, 107
BMI	27.6 ± 5.5, 27, 19–50, 102

Catheter type	n/N (%)
Foleyⁱ	63/107 (58.9%)
Intermittentⁱ	40/107 (37.4%)
Unconfirmed catheter type	6/107 (5.6%)

Bladder health
Trabeculation	64/107 (60.0%)
Cystitis	11/107 (10.3%)
Diverticulum	22/107 (20.6%)

Medical history
Genitourinary other than urinary retention	90/107 (84.1%)
Cardiovascular	88/107 (82.2%)
Endocrine/metabolic	69/107 (64.5%)
Medical and surgical procedures	50/107 (46.7%)
Gastrointestinal	41/107 (38.3%)
Musculoskeletal	30/107 (28.0%)
Psychiatric	28/107 (26.2%)
Neurological	18/107 (16.8%)
Respiratory	18/107 (16.8%)
HEENT (head, eyes, ears, nose, and throat)	14/107 (13.1%)
Hematologic/lymphatic	14/107 (13.1%)
Allergic/immunologic	9/107 (8.4%)
Dermatological	4/107 (3.7%)
Substance abuse	4/107 (3.7%)
General	1/107 (0.9%)

Baseline data for all enrolled patients including medical history categorized by Charlson Comorbidity Index. ⁱTwo patients reported both Foley and intermittent catheter use and are included in both groups.